logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
S

Seul Gi Lee

department of microbiology
H指数:21
被引数:1,166

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Comparing Outcomes With Subcutaneous Infliximab (CT-P13 SC) by Baseline Immunosuppressant Use: A Post Hoc Analysis of the LIBERTY-CD and LIBERTY-UC Studies

比较基线免疫抑制剂使用情况下的皮下注射英夫利昔单抗（CT-P13 SC）结局：LIBERTY-CD和LIBERTY-UC研究的回顾性分析

INFLAMMATORY BOWEL DISEASES
IF4.3
2025-04-300
PRE
Schreiber, Stefan; Colombel, Jean-Frederic; Hanauer, Stephen B.; Sandborn, William J.; Danese, Silvio; Lee, Sang Joon; Kim, Sung Hyun; Bae, YunJu; Lee, SunHee; Lee, Seul Gi; Kim, Jong Min; Park, GaHee; Lee, Jimin; Lee, Ju Hyun; Kim, ChaeYoung; Sands, Bruce E.
A Randomized Clinical Trial of Regdanvimab in High-Risk Patients With Mild-to-Moderate Coronavirus Disease 2019
OPEN FORUM INFECTIOUS DISEASES
IF3.8
2022-08-0816
OAAI
Kim, Jin Yong; Sandulescu, Oana; Preotescu, Liliana-Lucia; Rivera-Martinez, Norma E.; Dobryanska, Marta; Birlutiu, Victoria; Miftode, Egidia G.; Gaibu, Natalia; Caliman-Sturdza, Olga; Florescu, Simin-Aysel; Shi, Hye Jin; Streinu-Cercel, Anca; Streinu-Cercel, Adrian; Lee, Sang Joon; Kim, Sung Hyun; Chang, Ilsung; Bae, Yun Ju; Suh, Jee Hye; Chung, Da Rae; Kim, Sun Jung; Kim, Mi Rim; Lee, Seul Gi; Park, Gahee; Eom, Joong Sik
Efficacy and Safety of Regdanvimab (CT-P59): A Phase 2/3 Randomized, Double-Blind, Placebo-Controlled Trial in Outpatients With Mild-to-Moderate Coronavirus Disease 2019
OPEN FORUM INFECTIOUS DISEASES
IF3.8
2022-02-0236
OAAI
Streinu-Cercel, Anca; Sandulescu, Oana; Preotescu, Liliana-Lucia; Kim, Jin Yong; Kim, Yeon-Sook; Cheon, Shinhye; Jang, Young Rock; Lee, Sang Joon; Kim, Sung Hyun; Chang, Ilsung; Suh, Jee Hye; Lee, Seul Gi; Kim, Mi Rim; Chung, Da Rae; Kim, Han Na; Streinu-Cercel, Adrian; Eom, Joong Sik
Safety, Virologic Efficacy, and Pharmacokinetics of CT-P59, a Neutralizing Monoclonal Antibody Against SARS-CoV-2 Spike Receptor-Binding Protein: Two Randomized, Placebo-Controlled, Phase I Studies in Healthy Individuals and Patients With Mild SARS-CoV-2 Infection
CLINICAL THERAPEUTICS
IF3.6
2021-10-0144
OAAI
Kim, Jin Yong; Jang, Young Rock; Hong, Jang Hee; Jung, Jin Gyu; Park, Jae-Hyeong; Streinu-Cercel, Adrian; Streinu-Cercel, Anca; Sandulescu, Oana; Lee, Sang Joon; Kim, Sung Hyun; Jung, Na Hyun; Lee, Seul Gi; Park, Jeong Eun; Kim, Min Kyung; Jeon, Da Bee; Lee, Yeo Jin; Kim, Bum Soo; Lee, Yeon Mi; Kim, Yeon-Sook

研究方向

暂未获取到该数据
J
Ju‐Ock Nam
H 指数:21论文数:112被引数:2,083
T
Taeg Kyu Kwon
H 指数:68论文数:481被引数:2.4万
J
Jongbeom Chae
H 指数:7论文数:21被引数:136
S
Sang Joon Lee
H 指数:26论文数:65被引数:3,317
A
Adrian Streinu‐Cercel
H 指数:30论文数:400被引数:4,035
O
Oana Săndulescu
H 指数:22论文数:178被引数:2,032
S
Sung Hyun Kim
H 指数:27论文数:223被引数:2,818
J
Jin Yong Kim
H 指数:33论文数:199被引数:6,137
S
Streinu-Cercel, Anca
H 指数:0论文数:1被引数:3
S
Seon Min Woo
H 指数:25论文数:75被引数:1,559